# A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus

> **NCT01707147** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 3219 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Trajenta tablet

## Key facts

- **NCT ID:** NCT01707147
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-16
- **Primary completion:** 2017-07-11
- **Final completion:** 2017-07-11
- **Target enrollment:** 3219 (ACTUAL)
- **Last updated:** 2019-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01707147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01707147, "A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01707147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*